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Activation of tyrosine kinaae growth factor receptors leads to autophosphorylation f specific tyrosine residues within 
the intracellular region of the receptor. The phosphorylated tyrosines serve as binding sites for various cytoplasmic proteins. 
The Shc protein is one such protein. Upon activation of the chicken c-erbB protein by ligand Shc binds to the c-erbB protein 
and becomes phosphorylated on tyrosine. Similarly, Shc is found bound to the constitutively phosphorylated v-erbB protein 
encoded by the avian erythroblastosis virus strain H, AEV-H. Utilizing various mutant forms of the v-erbB protein, the residue 
equivalent to tyrosine 1154 in the chicken c-erbB protein was shown to serve as a binding site for the Shc protein to the 
AEV-H v-erbB protein. However, binding to this site was not essential for. transformation since v-erbB oncopr.oteins which 
lacked this site still transform both erythroid cells and fibroblasts. © 1995 Academic Press, Inc. 
INTRODUCTION 
Ligand-induced activation of growth factor receptor, 
GFR, protein tyrosine kinases initiates an intracellular 
cascade of phosphorylation reactions which are central 
to the subsequent cellular response. The initial biochemi- 
cal response to ligand binding is the autophosphorylation 
0fthe receptor on specific tyrosine residues. These auto- 
phosphorylation sites then serve as binding sites for in- 
tracellular proteins. Several of these intracellular proteins 
have been characterized and have been shown to con- 
tain src homology 2 (SH2) domains. SH2 domains are 
noncatalytic elements within proteins that have the ability 
to bind to specific tyrosine-phosphorylated sites (Koch 
eta/., 1991; Pawson and Gish, 1992). Among the various 
SH2 domain proteins that have been identified as binding 
to autophosphorylated GFRs, two have been implicated 
in the activation of the ras signal transduction pathway 
by protein tyrosine kinase GFRs. These are the proteins 
Shc and Grb2. 
Grb2 contains one SH2 domain and two SH3 domains. 
The SH2 domain has been shown to be responsible for 
the binding of Grb2 to certain tyrosine phosphorylated 
GFRs, such as the epidermal growth factor receptor, 
EGFR (Lowenstein eta/., 1992). In addition, the SH2 do- 
main of Grb2 can bind to tyrosine-phosphorylated Shc. 
The SH3 domains of Grb2 are responsible for the binding 
of the Grb2 protein to the ras GDP-GTP exchange pro- 
tein Sos (Li et a/,, 1993; Gale eta/., 1993; Buday and 
Downward, 1993a). The shc gene encodes three proteins 
as a result of a combination of alternative splicing and 
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alternative translational initiation (Pelicci et aL, 1992). All 
of these proteid~s contain a single C-terminal SH2 do- 
main, an N-terminal glycine/proline rich sequence, and 
no obvious catalytic domain. They have been demon- 
strated to be intracellular targets for phosphorylation by 
both nontransmembrane tyrosine kinases such as v-src 
and v-fps, as well as for growth factor stimulated recep- 
tors, such~a~s the EGF-R, insulin receptor, and the nerve  
growth facte.r receptor (Rozakis-Adcock et aL, 1992; 
McGlade et aL, 1992; Pelicci et aL, 1992; Pronk et aL, 
1993). The SH2 domain of Shc is responsible for the 
binding to tyrosine-phosphorylated EGFR. Overex- 
pression of the shc gene results in the malignant trans- 
formation of NIH 3T3 cells and induces ras-dependent 
neurite extension in the P012 pheochromocytoma neu- 
ronal cell line (Rozakis-Adcock et al., 1992; Pelicci et aL, 
1992). Thus, like Grb2, it has been implicated as being 
involved in linking signaling from GFRs to Ras. 
The binding of these two SH2 domain proteins to phos- 
photyrosine residues on activated GFRs is thought to be 
important in propagating the signal from the receptor to 
the Ras protein. Neither of these two SH2 domain pro- 
teins has any known catalytic activity. Thus, it has been 
postulated that the important signaling event is the for- 
mation of the complex itself (Buday and Downward, 
1993b; Pawson and Schlessinger, 1993). This changes 
the intracellular localization of these key signaling mole- 
cules, moving them into a functional part of the cell, 
namely, the plasma membrane. This implies that the 
binding of these two proteins to the receptor is a key 
initial event in the propagation of the signal. Therefore, 
it is important to determine the location of these binding 
sites within the specific receptor. 
The ligand-activated version of the chicken EGFR, c- 
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erbB, and its oncogenic counterpart encoded bythe AEV- 
H avian retrovirus, the v-erbB oncoprotein, can also bind 
to both Shc and Grb2 (496). A binding site for Grb2 to 
the mammalian EGFR has been reported as residue 1068 
(Pawson and Schlessinger, 1993) and this residue and 
the surrounding sequence is conserved in the chicken 
EGFR (Table 1). The binding site for Shc has been re- 
ported to be the carboxy-terminal phosphotyrosine resi- 
due of the human EGFR (Pawson and Schlessinger, 
1993) and this sequence and the surrounding amino 
acids is also conserved in the chicken EGFR (Table 1). 
Thus, the binding of Grb2 and Shc to the ligand-activated 
version of the chicken EGFR was to be expected. How- 
ever, it was surprising that the AEV-H protein bound to 
Shc since the proposed binding site is deleted in the 
AEV-H protein, implying that there was an additional in 
vivo binding site for the Shc protein on the chicken EGFR. 
Therefore, we determined the location of this binding 
site for~J.hc. The phosphotyrosine present at amino acid 
residue 11"54 in the chicken c-erbB protein (human equiv- 
alent 1148) was found to be able to serve as a binding 
site for the Shc protein. However, stable binding of the 
Shc protein to the v-erbB protein was not necessary for 
the Shc protein to become phosphorylated on tyrosine 
or for transformation. 
MATERIALS AND METHODS 
Cell culture and viruses 
Primary chicken embryo fibroblasts (CEF) were ob- 
tained from 7- to 8-day-old chicken embryos (Spafas) as 
described previously (Vogt, 1969). CEF were grown at 
37 ° with 7% CO2 in DMEM supplemented with 8% fetal 
calf serum and 2% chicken serum. The AEV-H deletion 
mutants have been described previously (Lee eta/., 
1993). 
Antibodies 
The monoclonal antibody 5E2 directed against phos- 
photyrosine was generously provided by Genentech (San 
Francisco, CA). The rabbit v-erbB/EGF-R antibody kn14 
and the rat monoclonal antibody 20.3 were generated 
against a 588-bp BamHI fragment encoding the v-erbB 
kinase domain as described previously (Hayman et aL, 
1986). The shc antiserum directed against the SH2 do- 
main of the shc protein was produced as described pre- 
viously (Pelicci eta/., 1992). Monoclonal antibody against 
the Grb2 protein was purchased from Transduction Labo- 
ratories (Lexington, KY). 
Immunoprecipitation and Western blotting 
All fibroblasts were lysed in 50 mM HEPES (pH 8.0), 
150 mM NaCI, 10% glycerol, 1% Triton X-100, 0.1% sodium 
dodecyl sulfate, 1 mM EGTA, 1.5 mM magnesium chlo- 
ride, 1 mM sodium orthovanadate. Lysates were immune 
precipitated and separated by sodium dodecyl sulfate- 
polyacrylamide gel electrophoresis (SDS-PAGE) and 
then immunoblotted as described previously (Crowe and 
Hayman, 1993). 
In Vitro binding studies 
The GST, GST-SHC(SH2), and GST-GRB2 bacterial 
proteins were induced and purified by binding to glutathi- 
one beads as described previously (Pelicci et al., 1992). 
Bacteria expressing the GST-GRB2 fusion protein were 
kindly provided by Dr. J. Bliska (Stony Brook, NY). The 
various cell lysates were incubated with these beads for 
90 min at 4 °. The beads were washed three times in lysis 
buffer and then boiled for 5 min in SDS sample buffer. The 
eluted proteins were resolved by SDS-PAGE followed by 
Western blotting. 
RESULTS 
SH2 domains have been shown to bind preferentially 
to phosphorylated tyrosine residues. The major differ- 
ence in the specificity of binding between the different 
SH2 domain proteins depends on the amino acids that 
are carboxy-terminal to the phosphorylated tyrosine resi- 
due (Zhou et aL, 1993). The binding sites for Grb2 and 
Shc to the human EGFR have recently been identified as 
the residues following tyrosines 1068 and 1173, respec- 
tively (Zhou eta/., 1993; Pawson and Schlessinger, 1993). 
The consensus sequence for Grb2 binding is pYXNX, 
where pY refers to phosphorylated tyrosine. Thus, Grb2 
binds to the site pYINQ at tyrosine 1068 in the EGFR and 
pYVNV in the Shc protein. The binding site for Shc is 
less well defined (Songyang eta/., 1994); however, it has 
been reported to bind to the sequence pYLRV at tyrosine 
1173 in the EGFR (Pawson and Schlessinger, 1993). Ta- 
ble 1 shows a comparison of the known autophosphory- 
lation sites of the human EGFR to those of the chicken 
EGFR, c-erbB. The sequence around the chicken equiva- 
lent of tyrosine 1068 is very similar to that of the human 
EGFR and therefore Grb2 would be expected to bind 
to autophosphorylated c-erbB. Similarly, the sequence 
pYLRV is conserved in the chicken protein and thus Shc 
should bind this site. Recent observations have shown 
these predictions to be true, in that autophosphorylated 
c-erbB is complexed to both Grb2 and Shc (Meyer etaL, 
1994). However, these studies also demonstrated that 
Grb2 and Shc bound to the constitutively phosphorylated 
AEV-H v-erbB oncoprotein. As shown schematically in 
Fig. 1 this protein has a carboxy-terminal truncation of 
35 amino acids and thus has lost the tyrosine at 1179 
and would not be expected to be able to bind to Shc. 
Therefore, we wanted to study the binding of Shc to the 
erbB protein in greater detail. 
To do this we took advantage of a series of different 
forms of the v-erbB protein that were readily available 
and had been shown previously to be constitutively phos- 
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TABLE 1 
SEQUENCES SURROUNDING KNOWN TYROSINE AUTOPHOSPHORYLATION SITES IN THE EGFR 
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Residue a 
996/992 1071/1068 1090/1086 1154/1148 1179/1173 
Chicken c-erbB ADEYLVP APEYVNQ NQIYNNI NPDYQQD NPEYLRV 
Human EGFR ADEYLIP VPEYINQ NPVYHNQ NPDYQQD NAEYLRV 
Proposed binding site PLO-'y GRB2 ? ? SHC 
~The location of the tyrosine residue that is autophosphorylated is indicated; the first number refers to the location in the chicken c-erbB protein 
and the second to the location in the human EGFR. 
phorylated on tyrosine (Hayman and Enrietto, 1991; Lee 
eta/., 1993). Figure 1 shows schematically the structure 
of the c-erbB, wt v-erbB protein of AEV strain H, together 
with a selection of deletion mutant forms of the AEV-H 
protein. These deletions have removed several of the 
phosphotyrosine residues that could be serving as Shc 
binding sites. We tested the ability of these proteins to 
bind to Shc. Figure 2 shows the results of an in vitro 
analysis of the binding of the tyrosine phosphorylated 
forms of several of these erbB-encoded proteins to a Gst 
fusion protein containing the Shc SH2 domain. This 
assay has been used previously to demonstrate the bind- 
ing of the wt AEV-H v-erbB protein to Shc (Meyer et al., 
1994). As can be seen in Fig. 2, the mutant forms of the 
AEV-H proteins encoded b~ Ctlaracterization of infectious 
bound to the Shc SH2 domai 
cellular protein of approximately 100,000 Da also bound 
to the SH2 domain of Shc. Analysis of all of the other dl 
series of mutants, Fig. 1, revealed that they too could 
bind to the Gst-Shc protein (data not shown and Fig. 
5A). Since it was possible that this in vitro binding did 
not reflect physiological binding, we analyzed the in vivo 
association between Shc and v-erbB by coimmunopre- 
cipitation from cells expressing several of these mutant 
forms of the v-erbB protein. Cells expressing the various 
erbB-encoded proteins were lysed and immune precipi- 
tates formed with either normal rabbit serum as a nega- 
tive control or with antibodies against erbB or Shc. The 
precipitated proteins were then analyzed by SDS-PAGE 
followed by Western blotting with anti-phosphotyrosine 
antibodies. Figure 3 shows that when the Shc proteins 
are immune precipitated from cells infected with either 
wt AEV-H virus or the various mutant forms of v-erbB a 
tyrosine phosphorytated protein of the same molecular 
weight as v-erbB is coimmunoprecipitated with Shc in 
every case. To confirm that this was v-erbB, the Western 
blot was stripped of the phosphotyrosine antibody and 
reprobed with a monoclonal antibody against v-erbB 
(data not shown). 
Inspection of Fig. 1 indicates that all of the AEV-H 
proteins tested contain tyrosine 1154. 
RYMV cDNA clone s a candidate for the Shc binding site. To 
test this we analyzed by coimmune precipitation cells 
transformed by the v-erbB protein encoded by the ES4 
strain of AEV. This form of v-erbB contains an internal 
deletion and a truncation compared to AEV-H, (see Fig. 
1). Although the deletion does not effect any of the auto- 
phosphorylation sites the truncation removes the tyro- 
sine at residue 1154. Figure 4 shows that whereas the 
AEV-H-encoded v-erbB protein and ligand activated c- 
erbB coimmunoprecipitates with Shc, the AEV-ES4-en- 
coded v-erbB protein does not coimmunoprecipitate with 
1 TM KINASE DOMAIN 
556 TM KINASE DOMAIN 
1195 
996 t071 t090 1164 11~9 C-erbB 
1160 
096 1071 1090 115~ AEV-H 
, Y ~ ~ , wt v .erbB 
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1031m 1055 dl 3 
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FIG, 1, Schematic of the chicken EGFR and various forms of the v-erbB proteins showing the presence of the tyrosines that serves as autophosphory- 
lation sites. The position of the amino acids deleted in the mutants is indicated by a horizontal line. The numbers refer to the equivalent amino 
acids in the c-erbB protein. 
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FIG. 2. In vitro binding of the Shc SH-2 domain to erbB. Lysates were 
prepared from CEF transformed by the various AEV-H deletion mutants 
and incubated with either GST or GST-Shc(SH2) proteins as described 
under Materials and Methods, Bound proteins were detected by SDS- 
PAGE followed by Western blotting with antibody against phosphoty- 
rosine. 
Shc. However, it is interesting to note that the Shc protein 
is phosphorylated on tyrosine in the AEV-ES4-trans- 
formed fibroblasts to an equivalent extent to that found 
in AEV-H-transformed cells and following ligand activa- 
tion of c-erbB (Fig. 4). These data indicate that tyrosine 
1154 and the surrounding amino acids are responsible 
for binding of Shc to the erbB protein but that binding is 
not necessary for the tyrosine phosphorylation of Shc. 
Furthermore, since the AEV-ES4 v-erbB protein is able 
to transform both fibroblasts and erythroblasts (Hayman 
and Enrietto, 1991), these data also indicate that binding 
is not necessary for transformation. 
We also wanted to confirm the binding site for Grb2 
to the chicken c-erbB protein. This site has been mapped 
to tyrosine 1068 in the human receptor, which is equiva- 
lent to tyrosine 1071 in the chicken protein (Table 1). It 
has recently been shown that truncation of the chicken 
erbB protein to residue 1018 removed binding of Grb2 
200 
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AEV-H 1131-1 U I -3  U I -4  
FIG. 3. In vivo association of erbB and Shc. Lysates were prepared 
from CEF transformed by AEV-H and the deletion mutants. These were 
divided into three equal aliquots and then immune precipitates isolated 
using normal rabbit serum (NRS), anti-erbB, or anti-Shc antibodies. 
The immune precipitates were analyzed by SDS-PAGE followed by 
Western blotting with antibody against phosphotyrosine. 
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FIG. 4. The AEV-ES4 v-erbB protein does not bind Shc. Lysates were 
prepared from CEF transformed by AEV-H, AEV-ES4, or ligand-activated 
c-erbB, These were divided into three equal aliquots and immune pre- 
cipitates formed using normal rabbit serum (NRS), anti-erbB, or anti- 
Shc antibodies. The immune precipitates were analyzed by SDS-PAGE 
followed by Western blotting with antibody against phosphotyrosine. 
whereas truncation to residue 1074 did not (Meyer etaL, 
1994). Since the only autophosphorylation site that is 
different between these two mutants is tyrosine 1071, 
this indicates that this is a site for Grb2 binding. To 
determine if this was the only site for Grb2 binding we 
analyzed the mutant dl 4 for binding to Grb2 in vitro, 
since this mutant is lacking tyrosine 1071 (see Fig. 1). 
As shown in Fig. 5A, the dl 4-encoded erbB protein can 
still bind to Grb2. This indicates the presence of addi- 
tional Grb2 binding sites within the v-erbB protein. The 
consensus binding site for Grb2 is pYXNX and this se- 
quence occurs around tyrosine 1090 in addition to tyro- 
sine 1071 (Table 1). Therefore, we analyzed the other 
deletion mutant proteins for Grb2 binding in vitro. This 
analysis demonstrated that they too could bind to Grb2 
(Fig. 5B). The binding to dl 6 is particularly informative 
since this mutant is lacking both the tyrosine 1071 and 
1090 (see Fig. 1). Since previous data had demonstrated 
that Grb2 could not bind to tyrosine 996 (Meyer et aL, 
1994), these data indicate that in addition to tyrosine 
1071 the Grb2 protein can also bind to tyrosine 1154 
(see Fig. 1). This is not a consensus binding site for 
Grb2. However, it is known that Grb2 can bind to tyrosine 
phosphorylated Shc. Thus, the most likely explanation 
for binding at this site is that the Grb2 protein is bound to 
the tyrosine phosphorylated Shc protein which is already 
bound to the v-erbB protein at this site. 
DISCUSSION 
Activation of the tyrosine kinase GFRs induces auto- 
phosphorylation of the receptor. The phosphotyrosine 
residues then serve as binding sites for molecules that 
play key roles in propagating the signal into the interior 
of the cell. It has been demonstrated that SH2 domains 
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FiG. 5. In vitro binding of Grb2 to erbB. Lysates were prepared from CEF transformedby the various AEV-H deletion mutants. (A) The lysate from 
AEV-H dl 4 infected cells was incubated with GST, GST-Shc(SH2) or GBT-Grb2 proteins as described under Materials and Methods. Bound proteins 
were detected by SDS-PAGE followed by Western blotting with antibody against phosphotyrosine. TOL is an aliquot of total cell lysate equivalent 
to one-fifth that used for the binding experiment. (B) The lysates from the other deletion mutant forms of erbB were incubated with either GST or 
GST-Grb2 proteins. Bound proteins were detected by SDS-PAGE followed by Western blotting with antibody against phosphotyrosine. 
within the secondary molecules are responsible for the 
ability of these proteins to bind to the phosphotyrosine 
residues. Several mechanisms can be envisaged that 
would explain how this binding would function to propa- 
gate the signals. The binding could cause a conforma- 
tional change in the protein and thereby activate some 
innate function. There is evidence that this could be the 
mechanism by which PI-3 kinase can be activated 
(Shoelson et aL, 1993). The binding could provide an 
intimate contact between the receptor and the secondary 
protein which would allow the receptor to utilize the pro- 
tein as a substrate and this modification could activate 
the protein. This is thought to be in part the manner by 
which phospholipase C (PLC)-T is activated (Kim et al., 
1991). Third, the binding of the protein to the receptor 
would enact a relocalization of cytoplasmic proteins to 
the plasma membrane which might provide them with 
better access to their substrates. This has been postu- 
lated to be a mechanism for the activation of the Ras 
signal transduction pathway, where the Grb2/Sos pro- 
teins are recruited to the plasma membrane bound to 
the receptor either directly or indirectly via tyrosine phos- 
phorylated Shc (Buday and Downward, 1993a). In all of 
these mechanisms of activation binding would be ex- 
pected to play a major role. 
The data presented here indicate that a binding site 
f0rShc to the erbB proteins is tyrosine 1154. This residue 
is absent from the erbB protein encoded by the AEV 
ES4 retrovirus. The erbB protein encoded by this virus 
is capable of extremely efficient transformation of both 
erythroid cell and fibroblasts (reviewed in Hayman and 
Enrietto, 1991). Thus, it is clear that this residue can be 
deleted from the erbB protein and this does not effect 
the ability of the protein to induce cell growth and trans- 
formation. Expression of the AEV ES4 erbB protein in 
cells does induce the efficient phosphorylation of Shc on 
tyrosine even though these two proteins do not form a 
complex. Therefore, it is possible that activation of the 
Shc protein by tyrosine phosphorylation is important for 
transformation by erbB but that the formation of a com- 
plex between these two proteins is not an essential 
event. It is also clear that the phosphorylation of the 
Shc protein is induced by other tyrosine kinases in the 
absence of binding, for example, the insulin receptor and 
the v-sea oncoprotein (Skolnik et aL, 1993; Crowe et al., 
1994). Since these mechanisms exist within the cell for 
the phosphorylation of Shc in the absence of binding, 
it is possible that the erbB protein can induce these 
mechanisms. Thus, the Shc protein may not be phos- 
phorylated directly by the erbB protein but by some other 
tyrosine kinase and this is the reason why this reaction 
takes place so efficiently in the absence of binding be- 
tween the Shc protein and the erbB kinase. 
Since the completion of these studies an analysis of 
the interactions between the human EGFR and Shc have 
also identified two binding sites for the Shc protein (Soier 
et aL, 1994b). These are the sites around residue 1173 
and 1148, the latter being the equivalent site to the one 
identified in the v-erbB protein. Analysis of the interaction 
of SH-2 domains with their binding sites has indicated 
that the three amino acids carboxy-terminal to the tyro- 
sine play crucial roles in determining the specificity of 
the interaction (Zhou etaL, 1993; Songyang eta/., 1994), 
Inspection of the sequences around the sites for Shc 
binding in the human and avian proteins reveals that the 
three amino acids carboxy-terminal to the tyrosine are 
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quite different between these two sites (Table 1). How- 
ever, the three amino acids amino-terminal to the tyrosine 
do display signif icant sequence similarities. Both of the 
sites have the consensus sequence NXE/DY, where E 
and D are both acidic amino acids. This raises the possi- 
bility that the recognition site for Shc involves the amino 
acids amino terminal to the phosphorylated tyrosine and 
this represents a novel interaction. 
Recently, truncations of the human EGFR have been 
analyzed for their ability to phosphorylate Shc, and in- 
duce mitogen-activated kinase activity and mitogenicity. 
These studies also demonstrated that binding between 
Shc and the receptor was not necessary for any of these 
three signaling events (Gotoh et aL, 1994; Soler et al., 
1994b). This is consistent with the ability of the v-erbB 
protein to induce cell transformation in the absence of 
efficient binding. It is important to realize that other sub- 
strates of the EGFR that normally bind to the receptor 
and serve as substrates for tyrosine kinases have also 
been shown to be phosphowlated in the absence of bind- 
ing. For example, the tyrosine phosphorylation of the ras 
GTPase activating protein does not require association 
with the receptor (Soler et aL, 1993), Thus, the role of 
binding per se is presently unclear but it does not appear 
to be an essential interaction for growth factor receptor 
signaling. 
Recently, analysis of the binding of SH2 domain pro- 
teins to the phosphorylated tyrosines on the receptors 
has indicated signif icant differences between the differ- 
ent growth factor receptors. The platelet-derived growth 
factor receptor has served as a paradigm for the impor- 
tance of the binding sites in signaling (Pawson and 
Schlessinger, 1993). Mutation of single sites has abol- 
ished signaling through the SH2 domain protein that in- 
teracts with that site. This has served as evidence for 
the importance of these specific interactions. However, 
studies with the hepatocyte growth factor receptor have 
indicated that this receptor has a single bidentate bind- 
ing site, which serves as the docking site for a vast array 
of SH2 domain proteins (Ponzetto et aL, 1994). The site 
does not have any obvious specificity, but does appear 
important for signaling. The EGFR is an example of a 
different paradigm. In this receptor there appears to be 
a redundancy of binding sites, as shown here, the Shc 
protein has two binding sites, the Grb2 protein has more 
than one site, and similar studies by others have indi- 
cated that other SH2 domain proteins can bind to more 
than one site (Soler et aL, 1994a). Furthermore, the data 
presented here indicate that proteins can also bind via 
indirect mechanisms, for example, Grb2 can bind to Shc 
which is bound to the erbB proteins. This creates more 
redundancy and generates the possibi l ity for more com- 
plex interactions. Therefore, it appears as if the different 
receptors have evolved different strategies to activate 
second messengers within the cell. Why these different 
mechanisms exist is unclear. It is possible that these 
differences could at least in part explain the ability of 
these receptors to direct different biological responses 
when activated in the same cell. Further analysis will be 
necessary to resolve these issues. 
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